Arronax Nantes brings together all stakeholders in Nantes working on research and development in nuclear medicine.

This more particularly include the GIP ARRONAX, the laboratories CeisamCEMA-OnirisCRCI2NA, LS2NSubatech, the CRIP-Oniris core facility and the Nuclear Medicine departments of the University Hospital of Nantes and the ICO.

Arronax Nantes is a stakeholder in the I-SITE NExT, in close collaboration with the LabEx IRON and the SIRIC ILIAD.

our publications

  • How Efficient Are Monte Carlo Calculations Together With the Q-System to Determine Radioactive Transport Limits? Case Study on Medical Radionuclides, Maietta M, Haddad F, Avila S., Front Med. 13 juill 2022;9:675009.

  • Proton Irradiations at Ultra-High Dose Rate vs. Conventional Dose Rate: Strong Impact on Hydrogen Peroxide Yield, Blain G, Vandenborre J, Villoing D, Fiegel V, Fois GR, Haddad F, et al., Radiation Research, June 8, 2022.

our news

Our equipments